Oral fluoropyrimidine-induced severe hyperlipidemia
Authors
Bulent Yildiz
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey
Halil Kavgaci
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey
Evren Fidan
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey
Erdal Gungor
Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey
Halil O. Ersoz
Department of Endocrinology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey
Feyyaz Ozdemir
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey
Fazil Aydin
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey
Language: English
Page range: 627 - 630
Published online: Apr 13, 2018
Published in print: Aug 1, 2010
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Related subjects:
© 2018 Bulent Yildiz, Halil Kavgaci, Evren Fidan, Erdal Gungor, Halil O. Ersoz, Feyyaz Ozdemir, Fazil Aydin, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.